Angiotensin-Converting Enzyme Gene 2350 G/A Polymorphism Is Associated with Left Ventricular Hypertrophy but Not Essential Hypertension
Authors:
Open Access
- 1 January 2007
- journal article
- Published by Japanese Society of Hypertension in Hypertension Research
- Vol. 30 (1) , 31-37
Abstract
The angiotensin-converting enzyme (ACE) gene (ACE) is one of the most studied candidate genes related to essential hypertension (EH) and left ventricular hypertrophy (LVH). ACE rs4343 synonymous coding polymorphism (2350 G/A) is known among the polymorphisms of this gene to have the most significant effect on plasma ACE concentrations. The aim of the present study was to investigate the association of this polymorphism with EH and LVH in 440 subjects (246 EH patients and 194 controls) from a Chinese Han population. In this study, 2350 G/A genotypes were identified by polymerase chain reaction and restriction digestion in all study participants, and left ventricular mass was assessed by 2-mode echocardiography in 178 untreated EH patients. There was no significant difference in either genotype distribution (p=0.3659) or allele frequency (p=0.1453) between EH and control groups. In addition, the 2350 G/A polymorphism had no effect on blood pressure in either controls or untreated EH patients. The distribution of genotypes differed significantly when patients with LVH were examined, i.e., 14.71% GG, 54.41% GA, and 30.88% AA patients had this complication, and 36.36% GG, 42.73% GA, and 20.91% AA patients did not (p=0.0070). The LVH patients had a higher A allele frequency (58.09%) than patients without LVH (42.27%) (p=0.0037). Logistic regression analysis revealed that the association between the A allele and LVH was independent of age, blood pressure, and body mass index. The relative risk of LVH in patients bearing the A allele (GA+AA group) compared with that of GG hypertensive patients was 3.31 (95% confidence interval [CI]: 1.43 to 7.68). These findings suggest an association between LVH and the 2350A allele in hypertensive patients.Keywords
This publication has 31 references indexed in Scilit:
- Significant Target Organs for Hypertension and Cardiac Hypertrophy by Angiotensin-Converting Enzyme InhibitorsHypertension Research, 2004
- An Alternative Fast and Convenient Genotyping Method for the Screening of Angiotensin Converting Enzyme Gene PolymorphismsHypertension Research, 2003
- Polymorphism of the Angiotensin Converting Enzyme Gene and Blood Pressure in a Japanese General Population (the Shigaraki Study).Hypertension Research, 2002
- An Interaction between Systolic Blood Pressure and Angiotensin-Converting Enzyme Gene Polymorphism on Carotid Atherosclerosis.Hypertension Research, 2002
- Linkage and Association Analysis of Angiotensin I–Converting Enzyme (ACE)–Gene Polymorphisms with ACE Concentration and Blood PressureThe American Journal of Human Genetics, 2001
- Evidence for a Gene Influencing Blood Pressure on Chromosome 17Hypertension, 2000
- Angiotensin-Converting Enzyme in the Human HeartCirculation, 1995
- Abnormalities of glucocorticoid metabolism and the renin???angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressureJournal Of Hypertension, 1992
- Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertensionBiochemical and Biophysical Research Communications, 1992
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978